FDA approves Genetech’s Xolair injection for severe food allergies
HQ Team February 19, 2024: The Food and Drug Administration (FDA) has approved Genetech’s Xolair (omalizumab) injection for severe food allergies in certain adults.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 19, 2024: The Food and Drug Administration (FDA) has approved Genetech’s Xolair (omalizumab) injection for severe food allergies in certain adults.
By K. Leelamoni December 19, 2023: Recent reports about the FDA’s approval of gene therapy to treat Sickle Cell Anemia mark a major.
HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.